Johnson & Johnson Consumer Inc. says supporting a “#1 dermatologist recommended” claim for its Neutrogena personal care line once in an industry self-regulation review ought to be enough and it shouldn’t face additional challenges to the same claim.
The business of global consumer health, personal care, pharmaceutical and medical technology firm Johnson & Johnson will appeal a National Advertising Division decision, arguing a “#1 claim” for its Neutrogena personal care line challenged by L’Oréal USA
J&J plans to argue to BBB National Programs Inc